Walleye Capital
CLBT icon

Walleye Capital’s Cellebrite CLBT Stock Holding History

Walleye Capital’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$353K Buy
25,600
+19,300
+306% +$291K ﹤0.01% 2938
2025
Q4 		$114K Sell
6,300
-1,400
-18% -$25.1K ﹤0.01% 3818
2025
Q3 		$143K Buy
7,700
+5,500
+250% +$86.4K ﹤0.01% 3523
2025
Q2 		$35.2K Sell
2,200
-100
-4% -$1.78K ﹤0.01% 4129
2025
Q1 		$44.7K Sell
2,300
-25,200
-92% -$530K ﹤0.01% 3884
2024
Q4 		$606K Sell
27,500
-53,400
-66% -$1.03M ﹤0.01% 2840
2024
Q3 		$1.36M Buy
+80,900
New +$1.2M ﹤0.01% 2326

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Walleye Capital's CLBT Position: Q1 2026 in Review

Walleye Capital sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 1 share — an estimated $15 sold.

Walleye Capital first reported a position in CLBT in Q4 2023 and held it in 9 quarters. The position peaked at $20M in Q3 2024. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Walleye Capital reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 1 Cellebrite share in Q1 2026, an estimated $15.
  • Walleye Capital first reported a position in Cellebrite in Q4 2023 and held it in 9 quarters.
  • Walleye Capital's Cellebrite position peaked at $20M in Q3 2024.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.